tiprankstipranks
MIRA Pharmaceuticals, Inc. (MIRA)
NASDAQ:MIRA
US Market

MIRA Pharmaceuticals, Inc. (MIRA) Financial Statements

36 Followers

MIRA Pharmaceuticals, Inc. Financial Overview

MIRA Pharmaceuticals, Inc.'s market cap is currently ―. The company's EPS TTM is $-0.807; its P/E ratio is -0.81; MIRA Pharmaceuticals, Inc. is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue----
Gross Profit----
EBIT$ -3.16M---
EBITDA----
Net Income Common Stockholders$ -3.59M$ -1.27M$ -1.34M-
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 5.87M$ 24.82K$ 1.35K$ 350.98K
Total Assets$ 9.02M$ 3.83M$ 397.58K$ 858.07K
Total Debt$ 34.53K$ 1.93M$ 360.55K$ 491.23K
Net Debt$ -5.83M$ 1.90M$ 359.20K$ 140.25K
Total Liabilities$ 902.90K$ 2.63M$ 2.19M$ 1.45M
Stockholders Equity$ 8.12M$ 1.20M$ -1.79M$ -596.23K
Cash Flow-
Free Cash Flow-$ -660.81K$ -1.08M-
Operating Cash Flow$ -1.76M$ -660.81K$ -1.08M-
Investing Cash Flow----
Financing Cash Flow$ 7.60M$ 684.29K$ 725.68K-
Currency in USD

MIRA Pharmaceuticals, Inc. Earnings and Revenue History

MIRA Pharmaceuticals, Inc. Debt to Assets

MIRA Pharmaceuticals, Inc. Cash Flow

MIRA Pharmaceuticals, Inc. Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis